Member News

Burnet Institute and ARTES join forces to develop novel hepatitis C vaccine

27th July, 2016 The Melbourne based Burnet Institute and ARTES Biotechnology announce they have joined forces to develop a novel, effective vaccine to prevent transmission of hepatitis C virus (HCV). An HCV vaccine is urgently needed to prevent…

Genetics of autism and gut changes the focus of new research & industry partnership

21st July 2016 University of Melbourne researchers have teamed up with industry to explore the genetics underlying the relationship between autism and changes to the gut. University of Melbourne researchers have teamed up with industry to explore the…

AIDS 2016 Durban: HIV cure hope of Nobel prize winner Francoise Barre-Sinoussi and Australia’s Sharon Lewin

21st July 2016 If YOU had been responsible for discovering why otherwise healthy people, in the prime of their lives, were dropping dead, you might be a little bit pleased with yourself. Not so for Francoise Barre-Sinoussi. “It…

Blood test could pick up Alzheimer’s disease clues long before symptoms show

21st July 2016 Scientists are close to developing a blood test to detect Alzheimer’s disease years before symptoms appear.La Trobe University researchers have identified abnormalities in the blood linked to the degenerative condition, which affects more than 350,000…

Curtin Medal recognises Institute director’s contributions to medical researc

1st July, 2016 – Professor Doug Hilton, director of the Walter and Eliza Hall Institute, has been awarded The Curtin Medal for Excellence in Medical Research for his outstanding contributions to medical science. The award from The John…

CSIRO and 360BioLabs who have been successful in securing a CRC-P grant to develop an antibody based in vitro diagnostic for metastatic cancer

Congratulations to to BioMelbourne Network members – CSIRO and 360BioLabs – who have been successful in securing a CRC-P grant to develop an antibody based in vitro diagnostic for metastatic cancer. This is the first round of the…

‘Holy grail’ of breast cancer prevention in high-risk women may be in sight

June 21st, 2016 Walter and Eliza Hall Institute researchers have discovered that an existing medication could have promise in preventing breast cancer in women carrying a faulty BRCA1 gene. This could mean that women with high genetic risk…

Retiring LBT Innovations CEO Lusia Guthrie Appointed Chair of Clever Culture Systems AG

Adelaide, Australia, 10 June 2016: The co-founder and Chief Executive of Australian laboratory automation company LBT Innovations Limited (LBT), Mrs Lusia Guthrie, has been appointed Chair of Clever Culture Systems AG (CCS) for a 2-year period from June…

Home

News & opinion

Member Directory

Events